Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 7:05 PM View:  | Nevro Corp (NVRO) | 31-Mar-24 | Grant | 1,090 | -- | -- | 6% 17.4K to 18.49K | |
| 03-Jan-24 4:51 PM View: | Nevro Corp (NVRO) | 31-Dec-23 | Grant | 731 | -- | -- | 4% 16.66K to 17.4K | |
| 03-Oct-23 10:00 PM View: | Nevro Corp (NVRO) | 30-Sep-23 | Grant | 819 | -- | -- | 5% 15.85K to 16.66K | |
| 05-Jul-23 5:09 PM View: | Nevro Corp (NVRO) | 30-Jun-23 | Grant | 619 | -- | -- | 4% 15.23K to 15.85K | |
| 30-May-23 5:17 PM View: | Nevro Corp (NVRO) | 25-May-23 | Grant | 6,754 | -- | -- | 80% 8.47K to 15.23K | |
| 04-Apr-23 4:41 PM View: | Nevro Corp (NVRO) | 31-Mar-23 | Grant | 435 | -- | -- | 5% 8.04K to 8.47K | |
| 04-Jan-23 4:37 PM View: | Nevro Corp (NVRO) | 30-Dec-22 | Grant | 397 | -- | -- | 5% 7.64K to 8.04K | |
| 04-Oct-22 5:50 PM View: | Nevro Corp (NVRO) | 30-Sep-22 | Grant | 337 | -- | -- | 5% 7.3K to 7.64K | |
| 16-Sep-22 5:30 PM View: | 10x Genomics, Inc. (TXG) | 14-Sep-22 | Option Exercise | 10,000 | $11.48 | $114,800.00 | 42% 23.58K to 33.58K | |
| 05-Jul-22 8:30 PM View: | Nevro Corp (NVRO) | 30-Jun-22 | Grant | 331 | -- | -- | 5% 6.97K to 7.3K | |
| 17-Jun-22 5:13 PM View: | 10x Genomics, Inc. (TXG) | 15-Jun-22 | Grant | 2,120 | -- | -- | 10% 21.46K to 23.58K | |
| 27-May-22 9:02 PM View: | Nevro Corp (NVRO) | 26-May-22 | Grant | 4,155 | -- | -- | 147% 2.82K to 6.97K | |
| 17-May-22 5:30 PM View: | 10x Genomics, Inc. (TXG) | 16-May-22 | Option Exercise | 15,000 | $11.48 | $172,200.00 | 232% 6.46K to 21.46K | |
| 04-Apr-22 9:48 PM View: | Nevro Corp (NVRO) | 31-Mar-22 | Grant | 190 | -- | -- | 7% 2.63K to 2.82K | |
| 04-Jan-22 10:00 PM View: | Nevro Corp (NVRO) | 31-Dec-21 | Grant | 169 | -- | -- | 7% 2.46K to 2.63K | |
| 04-Jan-22 6:16 PM View: | 10x Genomics, Inc. (TXG) | 30-Dec-21 | Sale (Planned) | 1,500 | $150.38 | $225,569.00 | (19%) 7.96K to 6.46K | |
| 29-Nov-21 6:14 PM View: | 10x Genomics, Inc. (TXG) | 24-Nov-21 | Sale (Planned) | 1,500 | $150.06 | $225,084.00 | (16%) 9.46K to 7.96K | |
| 27-Oct-21 5:19 PM View: | 10x Genomics, Inc. (TXG) | 25-Oct-21 | Sale (Planned) | 1,500 | $166.32 | $249,478.00 | (14%) 10.96K to 9.46K | |
| 24-Sep-21 10:00 PM View: | 10x Genomics, Inc. (TXG) | 23-Sep-21 | Sale (Planned) | 1,500 | $159.04 | $238,562.00 | (12%) 12.46K to 10.96K | |
| 02-Sep-21 6:34 PM View: | Nevro Corp (NVRO) | 31-Aug-21 | Grant | 2,459 | -- | -- | 100% 0 to 2.46K | |
| 25-Aug-21 8:39 PM View: | 10x Genomics, Inc. (TXG) | 23-Aug-21 | Sale (Planned) | 1,500 | $162.06 | $243,087.00 | (11%) 13.96K to 12.46K | |
| 26-Jul-21 4:35 PM View: | 10x Genomics, Inc. (TXG) | 23-Jul-21 | Sale (Planned) | 1,500 | $183.67 | $275,500.00 | (10%) 15.46K to 13.96K | |
| 25-Jun-21 4:23 PM View: | 10x Genomics, Inc. (TXG) | 23-Jun-21 | Sale (Planned) | 1,500 | $199.95 | $299,923.00 | (9%) 16.96K to 15.46K | |
| 15-Jun-21 5:49 PM View: | 10x Genomics, Inc. (TXG) | 11-Jun-21 | Grant | 625 | -- | -- | 4% 16.33K to 16.96K | |
| 26-May-21 8:28 PM View: | 10x Genomics, Inc. (TXG) | 24-May-21 | Sale (Planned) | 1,500 | $161.16 | $241,746.00 | (8%) 17.83K to 16.33K | |
| 27-Apr-21 5:58 PM View: | 10x Genomics, Inc. (TXG) | 23-Apr-21 | Sale (Planned) | 1,500 | $193.08 | $289,623.00 | (9%) 16.5K to 15.0K | |
| 25-Mar-21 8:32 PM View: | 10x Genomics, Inc. (TXG) | 23-Mar-21 | Sale (Planned) | 1,500 | $174.63 | $261,939.00 | (7%) 20.83K to 19.33K | |
| 25-Mar-21 8:32 PM View: | 10x Genomics, Inc. (TXG) | 25-Jan-21 | Gift | 7,167 | -- | -- | 34% 20.83K to 28.0K | |
| 25-Mar-21 8:32 PM View: | 10x Genomics, Inc. (TXG) | 25-Jan-21 | Gift | 7,167 | -- | -- | (26%) 28.0K to 20.83K | |
| 01-Jun-20 7:16 PM View: | 10x Genomics, Inc. (TXG) | 29-May-20 | Option Exercise | 10,000 | $11.48 | $114,800.00 | 92% 10.83K to 20.83K | |
| 17-Apr-20 9:08 PM View: | Penumbra Inc (PEN) | 15-Apr-20 | Market Sale (Planned) | 2,500 | $169.28 | $423,204.00 | (2%) 157.85K to 155.35K | (11%) |
| 18-Mar-20 7:55 PM View: | Penumbra Inc (PEN) | 16-Mar-20 | Market Sale (Planned) | 2,500 | $154.36 | $385,901.00 | (2%) 160.35K to 157.85K | (21%) |
| 20-Feb-20 8:03 PM View: | Penumbra Inc (PEN) | 18-Feb-20 | Market Sale (Planned) | 2,500 | $190.70 | $476,761.00 | (2%) 162.85K to 160.35K | 2% |
| 03-Feb-20 8:18 PM View: | Penumbra Inc (PEN) | 30-Jan-20 | Market Sale (Planned) | 2,500 | $176.15 | $440,373.00 | (2%) 166.35K to 163.85K | (6%) |
| 16-Sep-19 4:16 PM View: | 10x Genomics, Inc. (TXG) | 16-Sep-19 | Acquisition (other) | 10,833 | -- | -- | 100% 10.83K to 21.67K | |
| 16-Sep-19 4:16 PM View: | 10x Genomics, Inc. (TXG) | 16-Sep-19 | Disposition (other) | 10,833 | -- | -- | (50%) 21.67K to 10.83K | |
| 14-Feb-20 10:00 PM View: | Penumbra Inc (PEN) | 26-Aug-19 | Gift | 1,000 | -- | -- | (< 1%) 166.35K to 165.35K | |
| 02-Aug-19 8:09 PM View: | Penumbra Inc (PEN) | 01-Aug-19 | Market Sale (Planned) | 5,000 | $169.37 | $846,824.00 | (3%) 171.35K to 166.35K | (11%) |
| 03-Jul-19 7:30 PM View: | Penumbra Inc (PEN) | 01-Jul-19 | Market Sale (Planned) | 5,000 | $159.96 | $799,802.00 | (3%) 176.35K to 171.35K | (17%) |
| 05-Jun-19 8:37 PM View: | Penumbra Inc (PEN) | 03-Jun-19 | Market Sale (Planned) | 5,000 | $142.89 | $714,461.00 | (3%) 181.35K to 176.35K | (31%) |
| 05-Jun-19 8:37 PM View: | Penumbra Inc (PEN) | 17-May-19 | Gift | 1,000 | -- | -- | (< 1%) 182.35K to 181.35K | |
| 03-May-19 7:22 PM View: | Penumbra Inc (PEN) | 02-May-19 | Market Sale (Planned) | 4,449 | $130.04 | $578,548.00 | (2%) 186.8K to 182.35K | (44%) |
| 03-May-19 7:22 PM View: | Penumbra Inc (PEN) | 01-May-19 | Market Sale (Planned) | 551 | $131.90 | $72,678.00 | (< 1%) 187.35K to 186.8K | (42%) |
| 30-Apr-19 8:19 PM View: | Penumbra Inc (PEN) | 29-Apr-19 | Payment of Exercise | 79,615 | -- | -- | (30%) 266.97K to 187.35K | |
| 03-Apr-19 6:52 PM View: | Penumbra Inc (PEN) | 01-Apr-19 | Market Sale (Planned) | 5,000 | $143.45 | $717,251.00 | (2%) 271.97K to 266.97K | (31%) |
| 13-Mar-19 6:15 PM View: | Penumbra Inc (PEN) | 11-Mar-19 | Market Sale (Planned) | 5,000 | $139.84 | $699,220.00 | (2%) 276.97K to 271.97K | (34%) |
| 01-May-18 8:07 PM View: | Penumbra Inc (PEN) | 28-Apr-18 | Payment of Exercise | 79,612 | $126.45 | $10,066,900.00 | (22%) 356.58K to 276.97K | (48%) |
| 29-Nov-17 8:07 PM View: | Penumbra Inc (PEN) | 28-Nov-17 | Market Sale (Planned) | 2,501 | $103.65 | $259,236.00 | (< 1%) 360.08K to 357.58K | (81%) |
| 29-Nov-17 8:07 PM View: | Penumbra Inc (PEN) | 27-Nov-17 | Market Sale (Planned) | 3,525 | $103.96 | $366,455.00 | (< 1%) 363.6K to 360.08K | (80%) |
| 27-Nov-17 7:44 PM View: | Penumbra Inc (PEN) | 24-Nov-17 | Market Sale (Planned) | 2,218 | $104.07 | $230,827.00 | (< 1%) 365.82K to 363.6K | (80%) |